The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Aug 24, 2017
Impact of metformin on cardiovascular disease: A meta-analysis of randomised trials among people with type 2 diabetes
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Aug 18, 2017
|Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Aug 18, 2017